Knowledge of cutaneous squamous cell carcinoma (cSCC) has evolved over the last few decades, and Emily Ruiz, MD, MPH, FAAD, a Dermatologist and Mohs Micrographic Surgeon at Brigham and Women’s Hospital in Boston, and Associate Professor of Dermatology at Harvard Medical School in Boston, MA, shares some of latest developments in prognosticating and treating cSCC. Dr. Ruiz gave a talk on this topic at the American Academy of Dermatology’s 2025 Annual Meeting in Orlando, FL.
